KYVERNA THERAPEUTICS, INC.

Profile

Company Names

KYVERNA THERAPEUTICS, INC.

Addresses

5980 HORTON STREET, SUITE 550, EMERYVILLE, CA 94608

Phone Numbers

5106268331

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$151,999,981.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2021-11-09 
$151,999,981.00 
$151,999,981.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DOMINIC 
 
BORIE 
EXECUTIVE OFFICER
KYVERNA THERAPEUTICS, INC.
JAMES 
 
CHUNG 
EXECUTIVE OFFICER
MORGAN STANLEY EMPLOYEE TALF FUND LP   |  MORGAN STANLEY EMERGING MARKETS LEADERS FUND (CAYMAN) LP   |  NANO FINANCIAL HOLDINGS, INC.   |  ALKHEMIST HOLDINGS INC.   |  KYVERNA THERAPEUTICS, INC.   |  BRIDGE AGENCY MBS FUND INTERNATIONAL LP   |  BRIDGE AGENCY MBS FUND LP   |  BRIDGE DEBT STRATEGIES FUND V INTERNATIONAL LP   |  BRIDGE DEBT STRATEGIES FUND V LP   |  BDS V REIT LLC
IAN 
 
CLARK 
DIRECTOR
DICHOTOMY PARTNERS LP   |  AVROBIO, INC.   |  OLEMA PHARMACEUTICALS, INC.   |  GYROSCOPE THERAPEUTICS LTD   |  KYVERNA THERAPEUTICS, INC.   |  ASHER BIOTHERAPEUTICS, INC.
FRED 
 
COHEN 
DIRECTOR
PROTEOGENIX INC   |  NODALITY INC   |  NODALITY, INC.   |  QUINTILES TRANSNATIONAL HOLDINGS INC.   |  CARDIODX INC   |  VERACYTE, INC.   |  FIVE PRIME THERAPEUTICS INC   |  XDX, INC.   |  NOVAQUEST HEALTHCARE INVESTMENT FUND, L.P.   |  REVAL HOLDINGS INC   |  NOVAQUEST HEALTHCARE INVESTMENT FUND III, L.P.   |  BNA CHICAGO LLC   |  NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P.   |  ROKA BIOSCIENCE, INC.   |  RAPID MICRO BIOSYSTEMS, INC.   |  AUXOGYN, INC.   |  CAREDX, INC.   |  PROGYNY, INC.   |  CELL DESIGN LABS, INC.   |  CHICKEN SOUP FOR THE SOUL ENTERTAINMENT, INC.   |  VIDA VENTURES, LLC   |  VVAG SPECIAL FUND LLC   |  ASKLEPIOS BIOPHARMACEUTICAL, INC.   |  VV ATREUS SPECIAL FUND LLC   |  VIDA VENTURES II, LLC   |  VIDA VENTURES II-A, LLC   |  ASCEND GENE + CELL THERAPIES LTD.   |  FIREFLY NEUROSCIENCE, INC.   |  KYVERNA THERAPEUTICS, INC.   |  ASCEND ADVANCED THERAPIES GROUP, INC.   |  OLLIN BIOSCIENCES, INC.
RYAN 
 
JONES 
EXECUTIVE OFFICER
MICROPHARMA LTD   |  FLORENCE HEALTHCARE, INC.   |  SPESANA INC.   |  WESTWIN ELEMENTS INC   |  KYVERNA THERAPEUTICS, INC.   |  ARLO FINANCIAL HOLDINGS, INC.
BRIAN 
 
KOTZIN 
DIRECTOR
PROGENITY, INC.   |  KYVERNA THERAPEUTICS, INC.
STEVE 
 
LIAPIS 
DIRECTOR
KYVERNA THERAPEUTICS, INC.   |  GARUDA THERAPEUTICS, INC.   |  MERGE BIO THERAPEUTICS CORP
PETER 
 
MAAG 
EXECUTIVE OFFICER, DIRECTOR
MOLECULARMD CORP.   |  CAREDX, INC.   |  KYVERNA THERAPEUTICS, INC.
BETH 
 
SPIEGELMAN 
DIRECTOR
KYVERNA THERAPEUTICS, INC.
DAN 
 
SPIEGELMAN 
DIRECTOR
KYVERNA THERAPEUTICS, INC.
KAREN 
 
WALKER 
EXECUTIVE OFFICER
KYVERNA THERAPEUTICS, INC.   |  H1 INSIGHTS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-11-07
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-11-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#